Systemic sclerosis in 2026: emerging paradigms from the World Scleroderma Congress.
Early detection of systemic sclerosis through imaging and biomarkers enables tailored treatment strategies before severe damage occurs.
The abstract reports systemic sclerosis is increasingly understood as a dynamic continuum of autoimmune/inflammatory and fibrotic mechanisms that can be identified through imaging, biohumoral, and functional insights, thus enabling a very early/early diagnosis, a risk stratification, and a precision-based therapeutic approach. This PubMed record was retained because it is relevant to treatment innovation.
What the study was
- Study design
- Observational or descriptive study
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Current opinion in rheumatology
Why it surfaced
Observational or descriptive study relevant to Novel therapeutics: immunotherapy, CAR-T, targeted therapy; scored conservatively from the PubMed abstract.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.